CLYM Latest Press Releases

-- April 8, 2026 --

Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026 Globe Newswire 7:00 AM

-- April 7, 2026 --

Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy Globe Newswire 7:00 AM

-- March 5, 2026 --

Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates Globe Newswire 7:00 AM

-- February 5, 2026 --

Climb Bio to Present at Upcoming Investor Conferences Globe Newswire 7:00 AM

-- January 8, 2026 --

Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026 Globe Newswire 7:00 AM

-- November 25, 2025 --

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software